BECAS
SALDAIN Leo
congresos y reuniones científicas
L. SALDAIN; S. VANZULLI; P. MARTINEZ-VAZQUEZ; J. BURRUCHAGA; E. SPENGLER; C. LANARI; P. ROJAS
Differential regulation of hormone receptors and Ki67 in luminal breast carcinomas and tumor-adjacent mammary glands by mifepristone treatment
AACR Annual Meeting 2023
Lugar: Orlando, Florida; Año: 2023;
L. SALDAIN; A. ELIA; G. PATACCINI; M. ABBA; C. LANARI; P. ROJAS
THE DEVELOPMENT OF LUNG METASTASIS IN A MOUSE LUMINAL BREAST CANCER MODEL DEPENDS ON ITS PREVAILING PROGESTERONE RECEPTOR ISOFORM
LXVIII REUNIÓN ANUAL DE LA SOCIEDAD ARGENTINA DE INVESTIGACIÓN CLÍNICA (SAIC)
Año: 2023;
L. SALDAIN; S. VANZULLI; E.A. SPENGLER; P. ROJAS
Morphological changes and regulation of hormone receptor-related proteins in breast cancer patients with higher levels of progesterone receptor A than B treated with mifepristone
ESMO Breast Cancer 2022
Lugar: Berlín; Año: 2022;
M. COIANIS; L. SALDAIN; C. LANARI; C. LAMB
DECIPHERING THE CAUSES FOR A LATE FIRST MEDICAL CONSULTATION AMONG BREAST CANCER PATIENTS WHO ATTEND A SUBURBAN BUENOS AIRES HOSPITAL
LXVII REUNIÓN ANUAL DE LA SOCIEDAD ARGENTINA DE INVESTIGACIÓN CLÍNICA (SAIC)
Año: 2022;
L. SALDAIN; S. VANZULLI; C. LANARI; P. ROJAS
REGULATION OF HORMONE-RELATED PROTEINS IN TUMOR-ADJACENT BREAST TISSUE BY MIFEPRISTONE TREATMENT
LXVII REUNIÓN ANUAL DE LA SOCIEDAD ARGENTINA DE INVESTIGACIÓN CLÍNICA (SAIC)
Año: 2022;
A. ELÍA; L. SALDAIN; H. GASS; C. LANARI
Regulation of PR, ER and plasma steroid hormones by mifepristone treatment in breast cancer patients from MIPRA trial
LXVI REUNIÓN ANUAL DE LA SOCIEDAD ARGENTINA DE INVESTIGACIÓN CLÍNICA (SAIC)
Año: 2021;